Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
about
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationEncephalitic alphavirusesPegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infectionAlpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infectionPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsViral vector-based influenza vaccines.Alphavirus vectors: development and potential therapeutic applications.Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.Virus-vectored influenza virus vaccines.Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons.Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.Mucosal and systemic adjuvant activity of alphavirus replicon particles.Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression systemAlphavirus vectors and vaccination.Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challengeVaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.
P2860
Q24634730-7882C68A-52A2-484F-ACDD-E2E6075712F4Q24655184-01593E47-D44E-4D37-8071-58E4AC9EBF48Q27469593-2324527A-7B69-4CF5-87A2-0AC02EBBF94BQ27481522-F3A42B23-2804-4C65-B026-E93EC8F5D30BQ28384852-F0A0E2A8-D9C3-46B5-A96F-75D276068DBDQ30390938-A42A055D-2AF9-4367-B19B-23686157A1BEQ30771556-80B2287C-7AC1-4549-81D1-DB237B087BEFQ33787304-9DA2DA8D-4030-4F6C-AB48-0BC9C9444B14Q33796546-82BA3FBF-9AC6-499F-BCF5-6D8292BA8372Q34102268-0BECC6CE-3E7F-415D-BB2A-3D223B8D4B83Q34332253-A900B0A7-8BC1-4362-9286-460A4CA831BCQ34357038-35E15A68-749F-42B1-B8F7-60C35F16F9DBQ34410789-77E695C6-1068-41F0-9330-51D5AE4C3F76Q34545923-65F182AC-44D2-4963-8D12-B05F3A15D0DCQ34754733-B064D0FD-5620-4B47-B569-B904BD06FA2AQ34812016-C9D6639C-8C7F-4223-AFA3-3A51DE7064BEQ34991116-3288C248-F08B-4A18-B645-779CF9FBDED8Q36315159-23291AFD-4055-4D78-BF8D-865205A94ACEQ36702201-CCAEC597-7478-4708-AE61-C87AC41B3A23Q37297052-4D8EB925-03F8-4263-9EA9-A508D72876ABQ37341090-E714FDCC-21C3-41BA-B416-A6A6A901096CQ37451959-6AB80328-E723-48EB-9C8D-42BA7C7CB8F4Q39588679-55F7B5B7-5279-494D-B38E-7EDD371BBF78Q40718459-1B0769DB-56CB-4D08-BB69-D488DE5120C1Q41230818-ABFBF160-D75B-41DC-B007-05A0962252DC
P2860
Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mucosal immunity induced by pa ...... litis virus vaccine candidate.
@en
type
label
Mucosal immunity induced by pa ...... litis virus vaccine candidate.
@en
prefLabel
Mucosal immunity induced by pa ...... litis virus vaccine candidate.
@en
P2093
P356
P1433
P1476
Mucosal immunity induced by pa ...... litis virus vaccine candidate.
@en
P2093
P304
P356
10.1006/VIRO.1996.8381
P407
P577
1997-02-01T00:00:00Z